Lenimax Pharmaceuticals Private Limited
About Lenimax Pharmaceuticals Private Limited
Data last updated:
Lenimax Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 04 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC118090. Its GSTIN is 32AADCL3558N1Z9 (Kerala).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Udayakumar Pezholil and Kandedath Govindankutty Pradeep.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Phase II 107 Prasuth Nilayam Saket Kapra Rr, Hyderabad, Telangana, India – 500062.
As per the financials filed for FY 2021, the company reported a revenue of ₹7.59 Lakh. For the same year it recorded a net loss of ₹1.78 Lakh (net margin -23.4%) and EBITDA of -₹1.56 Lakh (EBITDA margin -20.5%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Lenimax Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPhase II 107 Prasuth Nilayam Saket Kapra Rr, Hyderabad, Telangana, India – 500062
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Lenimax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lenimax Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Lenimax Pharmaceuticals Private Limited, buy the company report.
Financials of Lenimax Pharmaceuticals Private Limited
FY 2021 filings availableLenimax Pharmaceuticals Private Limited reported revenue of ₹7.59 Lakh for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 40% over three years. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.56 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.78 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -20.5% | |||
| Net Profit Margin | -23.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Lenimax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lenimax Pharmaceuticals Private Limited
Lenimax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Udayakumar Pezholil | Director | 04 Jul 2017 | 9 Years 3 Months | Current |
| Kandedath Govindankutty Pradeep | Director | 04 Jul 2017 | 9 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Lenimax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lenimax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lenimax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCL3558N1Z9 | Kerala | Active | 12 Sep 2017 |
To see the full GST registrations and return filing status of Lenimax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lenimax Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Kandedath Govindankutty Pradeep was appointed as Director on 04 Jul 2017.
Frequently asked questions
Lenimax Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 04 July 2017 (9+ years old) and is registered under CIN U24304TG2017PTC118090.
Lenimax Pharmaceuticals has 2 current directors:
- Udayakumar Pezholil - Director
- Kandedath Govindankutty Pradeep - Director
The latest financial statements of Lenimax Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lenimax Pharmaceuticals is 32AADCL3558N1Z9, registered in Kerala.
The CIN (Corporate Identification Number) of Lenimax Pharmaceuticals is U24304TG2017PTC118090. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lenimax Pharmaceuticals was incorporated on 04 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kandedath Govindankutty Pradeep was appointed as Director on 04 Jul 2017. Udayakumar Pezholil was appointed as Director on 04 Jul 2017.
The registered office of Lenimax Pharmaceuticals is at Phase II 107 Prasuth Nilayam Saket Kapra Rr, Hyderabad, Telangana, India – 500062.
Lenimax Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Lenimax Pharmaceuticals is active non-compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.